Eosinophilic bronchitis in asthma: A model for establishing dose-response and relative potency of inhaled corticosteroids
- 31 May 2006
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 117 (5) , 989-994
- https://doi.org/10.1016/j.jaci.2006.01.045
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroidsAnnals of Allergy, Asthma & Immunology, 2003
- Low Dose Inhaled Budesonide and Formoterol in Mild Persistent AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- AsthmaNew England Journal of Medicine, 2001
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellantJournal of Allergy and Clinical Immunology, 1999
- Systemic Bioavailability and Potency of High-Dose Inhaled CorticosteroidsChest, 1999
- Establishing a therapeutic index for the inhaled corticosteroids: Part I: Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroidsJournal of Allergy and Clinical Immunology, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- Effect of an Inhaled Corticosteroid on Airway Inflammation and Symptoms in AsthmaAmerican Review of Respiratory Disease, 1992